All SEC Filings

Filing Type:

Year:

Date	Form	Description	Pages
07/02/20	S-1	General form of registration statement for all companies including face-amount certificate companies Documents EX-5 EX-23	199
07/01/20	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	7
06/30/20	8-K	Current report filing Documents EX-3 EX-20	5
06/25/20	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31 EX-32	76
06/24/20	10-K/A	Annual report pursuant to Section 13 and 15(d) Documents EX-31 EX-31 EX-32	127
06/19/20	8-K	Current report filing Documents EX-10 EX-10	34
06/16/20	8-K	Current report filing Documents EX-10	8
06/15/20	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-5 EX-23	12
06/09/20	4	Statement of changes in beneficial ownership of securities	2
05/29/20	4	Statement of changes in beneficial ownership of securities	2

Food and Drug Administration (FDA) Disclosure

Statements in this website have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease. Always check with your physician before starting a new wellness or dietary program. Please view our full terms of use agreement for more information and the terms and conditions governing your use of this site. Cannabidiol (CBD) is a natural derivative of cannabis plants that promote and support nutrition, health and wellness, as well as anti-aging. Source: US Government Patent #6,630,507: "cannabinoids as antioxidants and neuroprotectants."

Marijuana Company of America, Inc. (MCOA) does not sell or distribute any products that are in violation of the united states controlled substances act (US CSA) in California. MCOA grows, produces, sells and distributes solutions for health, wellness, and anti-aging companies. MCOA solutions include cannabis- and/or CBD/CBN-based elements. Where allowed, MCOA may sell or distribute solutions containing THC. For more information, please contact us.